---
title: "Response of Postoperative and Chronic Uveitic Cystoid Macular Edema to a Dexamethasone-Based Intravitreal Implant (Ozurdex)"
date: 2016-09-01
publishDate: 2023-03-26T14:32:44.331562Z
authors: ["J. G. Garweg", "E. Baglivo", "F. J. Freiberg", "M. Pfau", "I. B. Pfister", "S. Michels", "S. Zandi"]
publication_types: ["2"]
abstract: ")). This retrospective, interventional case series reports on patients with chronic CME after uncomplicated vitrectomy for epiretinal gliosis or phacoemulsification (group 1: 12 eyes) or secondary to noninfectious endogenous uveitis (group 2: 36 eyes). Central retinal thickness (CRT), best-corrected visual acuity (BCVA, logMAR), and intraocular pressure (IOP) throughout follow-up were gleaned from the medical records. 3.4 months for postoperative and uveitic CME, respectively. Ozurdex seems to achieve a sustained effect over up to 6 months in postsurgical and uveitic CME."
featured: false
publication: "*J Ocul Pharmacol Ther*"
---

